Breast cancer differ, for example, with respect to oestrogen (ER) and progesterone receptor (PR) status; hormone receptor-positive cancers exhibiting better differentiated morphological appearance and stronger clinical response to hormonal treatment (Althuis et al, 2004). Here, NR4A1 is linked to breast cancer.